Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study

Rachel Strykowski; Divya C Patel; Manny Ribeiro Neto; Kerry M Hena; Mridu Gulati; LIsa A Maier; Karen Patterson

doi:10.1136/bmjresp-2022-001254

Article info

PDF

Interstitial lung disease

Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study

Authors

Rachel Strykowski Department of Medicine, Section of Pulmonary and Critical Care, University of Chicago, Chicago, Illinois, USA PubMed articles Google scholar articles
Divya C Patel Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, Florida, USA PubMed articles Google scholar articles
Manny Ribeiro Neto Pulmonary Medicine, Respiratory Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA PubMed articles Google scholar articles
Kerry M Hena Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, New York University, New York, New York, USA PubMed articles Google scholar articles
Mridu Gulati Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA PubMed articles Google scholar articles
LIsa A Maier Divisions of Cardiology and Pulmonary Medicine, National Jewish Health, Denver, Colorado, USA PubMed articles Google scholar articles
Karen Patterson Medicine, Pulmonary, Allergy and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania, USAMedicine, Brighton and Sussex Medical School, Brighton, UK PubMed articles Google scholar articles

Correspondence to Dr Rachel Strykowski; rachel.strykowski{at}uchospitals.edu

View Full Text

Citation

Strykowski R, Patel DC, Neto MR, et al

Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study

BMJ Open Respiratory Research 2022;9:e001254. doi: 10.1136/bmjresp-2022-001254

Publication history

Received March 23, 2022
Accepted June 11, 2022
First published July 26, 2022.

Online issue publication

October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.